Optimizing Therapy for Patients with Acute and Chronic Graft-Versus-Host Disease (GvHD) - Episode 4
Treatment options for steroid refractory acute GvHD, including ruxolitinib efficacy and NCCN guideline adherence, take center stage in the discussion.